An experimental gene therapy could offer new hope for patients living with retinitis pigmentosa, a group of inherited retinal diseases that can lead to progressive vision loss. Sulagna Bhattacharya, co founder and CEO of Nano Scope Therapeutics, shares how her own family’s experience with RP inspired her mission to develop new treatment options.
Bhattacharya explains why retinitis pigmentosa has been particularly challenging to treat. Because...
The future of investing is rapidly evolving as tokenization brings real-world assets onto blockchain networks. In this interview, Ashley Ebersole, co-founder of tx, joins J.D....
In this interview, Felix Huang, Group Global Partner at Tiger Brokers, joins to discuss the company’s global expansion, its role connecting Asian investors with U.S....
In this interview sit down with Kyle Jenke, Chief Business Officer at Optimism, to discuss why 2026 could be a defining year for blockchain adoption among...
In this interview, Jessica Holzbach, Partner and CEO Germany at OT09, joins in to discuss Europe’s startup ecosystem, the funding gap, regulatory fragmentation, and what...
In this episode, Co-Host Marisa Estrada Rivera has an engaging conversation with Malik Corbett, an 'Uber entrepreneur,' about his experience as an early DeFi...
In this episode, Amanda Whitcroft and Tony Edward discuss Michael Saylor and Strategy’s Bitcoin controversy, Jim Cramer’s comments on a potential SpaceX IPO versus...
Alexandre Morin, Director of Payments, Risk and Fintech at Wego, the number one travel app and largest online travel marketplace in the MENA region,...
FinTech TV, recently unveiled a major upgrade: the FinTech TV Terminal, powered through a strategic partnership with Tap. The terminal delivers real-time breaking news, live...